Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Krebs Biochemicals & Industries Ltd Q2 FY27 key numbers
- Revenue
- Revenue from Operations for the quarter ended September 30, 2026: Rs. 579.03 lakhs.
As stated in Krebs Biochemicals & Industries Ltd's Q2 FY27 results statement · published 29 Oct 2026. Reported figures, not investment advice.
Based on Krebs Biochemicals & Industries Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from Operations for the quarter ended September 30, 2026: Rs. 579.03 lakhs. EBITDA for the quarter ended September 30, 2026: Rs.
From Krebs Biochemicals & Industries Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.
How did Krebs Biochemicals & Industries' revenue grow in the September 2026 quarter?
- Revenue from Operations for the quarter ended September 30, 2026: Rs. 579.03 lakhs
- Revenue from Operations for the corresponding quarter ended September 30, 2025: Rs. 416.74 lakhs
- Year-on-year revenue increase: Rs. 579.03 - Rs. 416.74 = Rs. 162.29 lakhs (approx. 38.9% increase)
What happened to Krebs Biochemicals & Industries' margins in Q2 FY27?
See what Krebs Biochemicals & Industries Ltd said on profitability & margins — free account, 30 seconds.
What capex is Krebs Biochemicals & Industries planning?
See what Krebs Biochemicals & Industries Ltd said on capital expenditure plans — free account, 30 seconds.
Is Krebs Biochemicals & Industries raising money or cutting debt?
See what Krebs Biochemicals & Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Krebs Biochemicals & Industries' order book?
See what Krebs Biochemicals & Industries Ltd said on order book & pipeline — free account, 30 seconds.
Krebs Biochemicals & Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹6 Cr, net loss ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Krebs Biochemicals & Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Krebs Biochemicals & Industries Ltd Q2 FY27 results?
Revenue from Operations for the quarter ended September 30, 2026: Rs. 579.03 lakhs. EBITDA for the quarter ended September 30, 2026: Rs.
What is Krebs Biochemicals & Industries Ltd share price analysis?
Krebs Biochemicals & Industries Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹125 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Krebs Biochemicals & Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.